The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Cadence sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData


Premium Insights Cadence Inc, United States Revenue

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

Cadence is a leading contract manufacturer of medical and drug delivery devices. The company’s product portfolio includes analytical probes, aortic punches and vessel cutters, biopsy punches, lancets, stylets, bone saws and shaver blades, cannulas, introducers, catheter slitters, complex robotic solutions, complex sub-assemblies, critical components and others. It also offers other life science and industrial products. Cadence serves medical (surgical); diagnostics (pharma – lab); drug delivery; ophthalmic; point-of-care; industrial and specialty commercial; aerospace (defence – firearms) and automotive markets. It offers products under cadence brand. The company operates in Connecticut, Pennsylvania, Rhode Island, Wisconsin, and Costa Rica. Cadence is headquartered in Staunton, Virginia, the US. Key subsidiaries of Cadence include Specialty Blades, Utitec, IncisionTech and Cadence Science.

The key metrics of Cadence related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:

As Cadence is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Cadence.

For a detailed understanding of the performance of Cadence, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.